title: Reproductive performance after selective tubal catheterization.
abstract: OBJECTIVE
  To evaluate the reproductive performance of women after selective tubal catheterization.
  
  
  METHODS
  Retrospective study (Canadian Task Force classification II-3).
  
  
  METHODS
  University teaching hospital.
  
  
  METHODS
  Ninety-eight infertile women with hysterosalpingographic findings of proximal tubal occlusion.
  
  
  METHODS
  Hysterosalpingography and selective tubal catheterization.
  
  
  RESULTS
  Repeat hysterosalpingography examination before selective tubal catheterization in 98 patients revealed bilateral tubal patency in 14 patients and patency of one of the tubes in 12 others (12.2%). True proximal tubal occlusion was encountered in 72 patients (139 tubes). Successful recanalization of both tubes was achieved in 25 patients (34.7%), and successful recanalization of at least one tube was achieved in 44 patients (61.1%). Of the 72 patients who underwent selective tubal catheterization, 23 patients conceived. The cumulative probability of conception was 28%, 59%, and 73% at 12, 18, and 24 months of follow-up, respectively. The median procedure-conception interval was 16.2 months.
  
  
  CONCLUSIONS
  One-quarter of patients diagnosed with bilateral proximal tubal occlusion on hysterosalpingography do not have tubal obstruction. Among those with true occlusion, selective tubal catheterization leads to an overall pregnancy rate of 31.9%.
authors.affiliation: Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
authors.forename: Dania
authors.initials: D
authors.lastname: Al-Jaroudi
authors.forename: Milton J
authors.initials: MJ
authors.lastname: Herba
authors.forename: Togas
authors.initials: T
authors.lastname: Tulandi
mesh_terms: D000328:Adult; D002404:Catheterization / Q000009:adverse effects / Q000379:methods*; D005184:Fallopian Tube Diseases / Q000175:diagnosis / Q000628:therapy*; D005186:Fallopian Tube Patency Tests / Q000379:methods*; D005187:Fallopian Tubes / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007047:Hysterosalpingography / Q000009:adverse effects / Q000379:methods*; D007247:Infertility, Female / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D018873:Pregnancy Rate; D011792:Quebec; D017584:Reproductive History; D012189:Retrospective Studies; D012680:Sensitivity and Specificity